n-benzyladriamycin-14-valerate has been researched along with acridine orange in 1 studies
| Studies (n-benzyladriamycin-14-valerate) | Trials (n-benzyladriamycin-14-valerate) | Recent Studies (post-2010) (n-benzyladriamycin-14-valerate) | Studies (acridine orange) | Trials (acridine orange) | Recent Studies (post-2010) (acridine orange) |
|---|---|---|---|---|---|
| 25 | 0 | 3 | 2,310 | 19 | 343 |
| Protein | Taxonomy | n-benzyladriamycin-14-valerate (IC50) | acridine orange (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darzynkiewicz, Z; Kapuscinski, J; Traganos, F | 1 |
1 other study(ies) available for n-benzyladriamycin-14-valerate and acridine orange
| Article | Year |
|---|---|
Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198.
Topics: Acridine Orange; Animals; Caffeine; Cell Cycle; Cell Division; Doxorubicin; Drug Interactions; Ellipticines; Flow Cytometry; Mice; Mitoxantrone; Nucleic Acids; Spectrophotometry | 1991 |